Advertisement

NCCN Guidelines for the Management of Immunotherapy-Related Toxicities (Version 1.2022)
Posted: 04/26/2022 | By: Sarah Campen, PharmD

Question 1 of 5

Which of the following actions are NOT recommended by the NCCN panel post–CAR T-cell infusion?

Choose 1